Biocytogen

Biocytogen company information, Employees & Contact Information

Explore related pages

Related company profiles:

Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ mice), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with more than 70% of the top 50 pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.
Looking for a particular Biocytogen employee's phone or email?

Biocytogen Questions

News

Biocytogen Upgrades Preclinical Service Platform and Launches Revamped Global Website - Business Wire

Biocytogen Upgrades Preclinical Service Platform and Launches Revamped Global Website Business Wire

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody - afp.com

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody afp.com

Biocytogen Responds to Harbour BioMed’s Patent Claims: RenNano® is an Independently Developed Platform with Distinct Innovation and Full Legal Standing - Business Wire

Biocytogen Responds to Harbour BioMed’s Patent Claims: RenNano® is an Independently Developed Platform with Distinct Innovation and Full Legal Standing Business Wire

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - afp.com

Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions afp.com

Press Release Service: Biocytogen Establishes Two Business Divisions to Distinguish Preclinical Models and Services (BioMice) From Antibody Drug R&D - CRISPR Medicine News

Press Release Service: Biocytogen Establishes Two Business Divisions to Distinguish Preclinical Models and Services (BioMice) From Antibody Drug R&D CRISPR Medicine News

IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen - PR Newswire

IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen PR Newswire

Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development - Business Wire

Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development Business Wire

IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen - PR Newswire

IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen PR Newswire

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009) - Business Wire

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009) Business Wire

Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform - Business Wire

Biocytogen Secures Japan Patent for RenMab Platform, Expands Global Patent Portfolio for RenMice Fully Human Antibody/TCR Platform Business Wire

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development - Business Wire

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development Business Wire

Biocytogen Announces Grand Opening of Waltham, MA Facility - Business Wire

Biocytogen Announces Grand Opening of Waltham, MA Facility Business Wire

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development - Business Wire

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development Business Wire

Biocytogen Officially Launches RenMice® Series - Business Wire

Biocytogen Officially Launches RenMice® Series Business Wire

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors - Business Wire

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors Business Wire

SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target - Business Wire

SOTIO Advances Colorectal Cancer ADC Program, SOT109, and Licenses Fully Human Antibodies from Biocytogen for Novel Tumor Target Business Wire

Busy period for Asia’s dealmakers has HBM, Biocytogen at the top - BioCentury

Busy period for Asia’s dealmakers has HBM, Biocytogen at the top BioCentury

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement - The AI Journal

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement The AI Journal

Ideaya pushes ahead with Biocytogen bispecific ADC bet - Fierce Biotech

Ideaya pushes ahead with Biocytogen bispecific ADC bet Fierce Biotech

Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany - PR Newswire

Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany PR Newswire

Ideaya, eyeing drug combos, bags option on Biocytogen bispecific ADC in $400M deal - Fierce Biotech

Ideaya, eyeing drug combos, bags option on Biocytogen bispecific ADC in $400M deal Fierce Biotech

SOTIO partners with Biocytogen to expand ADC pipeline - European Biotechnology Magazine

SOTIO partners with Biocytogen to expand ADC pipeline European Biotechnology Magazine

Sotio taps Biocytogen to create bispecific ADCs in $326M deal - Fierce Biotech

Sotio taps Biocytogen to create bispecific ADCs in $326M deal Fierce Biotech

GV Safety Assessment Platform (GVSAP) and Biocytogen Forge Strategic Collaboration to Accelerate Biopharmaceutical Innovation - Business Wire India

GV Safety Assessment Platform (GVSAP) and Biocytogen Forge Strategic Collaboration to Accelerate Biopharmaceutical Innovation Business Wire India

Biocytogen and LiberoThera reach landmark in development of Fully Human GPCR Antibody Drugs - World Business Outlook

Biocytogen and LiberoThera reach landmark in development of Fully Human GPCR Antibody Drugs World Business Outlook

China's Biocytogen partners with Merck to advance antibody-conjugated lipid-based delivery solutions - BioSpectrum Asia

China's Biocytogen partners with Merck to advance antibody-conjugated lipid-based delivery solutions BioSpectrum Asia

Biocytogen Awarded U.S. Patent for RenLite? Common Light Chain Mouse Platform - aap.com.au

Biocytogen Awarded U.S. Patent for RenLite? Common Light Chain Mouse Platform aap.com.au

Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody - Fierce Biotech

Keytruda killer: Chipscreen bags Chinese rights to Biocytogen's bispecific antibody Fierce Biotech

Biotech Firm Biocytogen Leases Full Floor at 300 Third Avenue in Waltham - Boston Real Estate Times

Biotech Firm Biocytogen Leases Full Floor at 300 Third Avenue in Waltham Boston Real Estate Times

RenMab™ Mouse Set to Become the Leading Platform for Generating Human Antibodies - Genetic Engineering and Biotechnology News

RenMab™ Mouse Set to Become the Leading Platform for Generating Human Antibodies Genetic Engineering and Biotechnology News

Top Biocytogen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant